Hypera S.A. HYPE3.SA Stock
Hypera S.A. Price Chart
Hypera S.A. HYPE3.SA Financial and Trading Overview
Hypera S.A. stock price | 30.05 BRL |
Previous Close | 45.84 BRL |
Open | 0 BRL |
Bid | 45.37 BRL x 0 |
Ask | 45.52 BRL x 0 |
Day's Range | 0 - 0 BRL |
52 Week Range | 0 - 51.11 BRL |
Volume | 0 BRL |
Avg. Volume | 4.79M BRL |
Market Cap | 28.76B BRL |
Beta (5Y Monthly) | 0.217808 |
PE Ratio (TTM) | 16.97388 |
EPS (TTM) | 2.58 BRL |
Forward Dividend & Yield | 1.23 (2.70%) |
Ex-Dividend Date | March 30, 2023 |
1y Target Est | 50.93 BRL |
HYPE3.SA Valuation Measures
Enterprise Value | 36.93B BRL |
Trailing P/E | 16.97388 |
Forward P/E | 12.67131 |
PEG Ratio (5 yr expected) | 1.22 |
Price/Sales (ttm) | 3.7104957 |
Price/Book (mrq) | 2.6639729 |
Enterprise Value/Revenue | 4.764 |
Enterprise Value/EBITDA | 14.128 |
Trading Information
Hypera S.A. Stock Price History
Beta (5Y Monthly) | 0.217808 |
52-Week Change | 20.06% |
S&P500 52-Week Change | 20.43% |
52 Week High | 51.11 BRL |
52 Week Low | 0 BRL |
50-Day Moving Average | 39.26 BRL |
200-Day Moving Average | 42.93 BRL |
HYPE3.SA Share Statistics
Avg. Volume (3 month) | 4.79M BRL |
Avg. Daily Volume (10-Days) | 7.39M BRL |
Shares Outstanding | 632.23M |
Float | 403.42M |
Short Ratio | N/A |
% Held by Insiders | 36.24% |
% Held by Institutions | 40.05% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 1.231 |
Trailing Annual Dividend Yield | 2.68% |
5 Year Average Dividend Yield | 358.00% |
Payout Ratio | 0.4641 |
Last Split Factor | 2:1 |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | 21.77% |
Operating Margin (ttm) | 32.39% |
Gross Margin | 63.32% |
EBITDA Margin | 33.72% |
Management Effectiveness
Return on Assets (ttm) | 7.31% |
Return on Equity (ttm) | 16.37% |
Income Statement
Revenue (ttm) | 7.75B BRL |
Revenue Per Share (ttm) | 12.26 BRL |
Quarterly Revenue Growth (yoy) | 13.70% |
Gross Profit (ttm) | 4.76B BRL |
EBITDA | 2.61B BRL |
Net Income Avi to Common (ttm) | 1.69B BRL |
Diluted EPS (ttm) | 2.68 |
Quarterly Earnings Growth (yoy) | -2.70% |
Balance Sheet
Total Cash (mrq) | 1.09B BRL |
Total Cash Per Share (mrq) | 1.72 BRL |
Total Debt (mrq) | 9B BRL |
Total Debt/Equity (mrq) | 83.16 BRL |
Current Ratio (mrq) | 1.96 |
Book Value Per Share (mrq) | 17.076 |
Cash Flow Statement
Operating Cash Flow (ttm) | 2.03B BRL |
Levered Free Cash Flow (ttm) | -662532224 BRL |
Profile of Hypera S.A.
Country | Brazil |
State | SP |
City | São Paulo |
Address | Av. Magalhães de Castro, 4800 |
ZIP | 05676-120 |
Phone | 55 11 3627 4206 |
Website | https://www.hyperapharma.com.br |
Industry | Drug Manufacturers-Specialty & Generic |
Sector(s) | Healthcare |
Full Time Employees | N/A |
Hypera S.A. operates as a pharmaceutical company in Brazil. It offers prescription products under the Adacne, Addera, apri, AmpliumG, please, Celestamine, Celestone, Celestone Soluspan, Cizax, deciprax, Derive C Micro, Micro Drift, Dermotil Fusid, Digedrat, diprogent, Diprosalic, Diprosone, diprospan, Emprol XR, Flow, Garasone, Halobex, Lipanon, moon, Lydian, macrodantin, MaxSulid, milgamma, Mioflex A, nesina, Novotram, oximax, peridal, Peridal Suspension, PredSim, pressaliv, Quadriderm, Rizi, Rizi M, softalm, tacroz, tinodin, umma, and velunid brands. The company also provides dermo-cosmetics products under the Mantecorp Skincare brands; and consumer health products under the Apracur, Benegrip, Coristina d, Engov, Epocler, Estomazil, and other brands. In addition, it offers nutritional and vitamin supplement products under the Tamarine, Vitasay, Biotônico Fontoura, and Zero-Cal brands; and similar and generic medicines under the Neo Química, Sodium Diclofenac, Hydroxyzine, Dipyron, Ibuprofen, Losartan Potassium, Mal Dexchlorpheniramine, Naproxene, Paracetamol, Simethicon, Loratadine, Omeprazole, Tadalaphyl, and Desogestrel brand names. The company was formerly known as Hypermarcas S.A. and changed its name to Hypera S.A. in February 2018. Hypera S.A. is based in São Paulo, Brazil.
Q&A For Hypera S.A. Stock
What is a current HYPE3.SA stock price?
Hypera S.A. HYPE3.SA stock price today per share is 30.05 BRL.
How to purchase Hypera S.A. stock?
You can buy HYPE3.SA shares on the São Paulo exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Hypera S.A.?
The stock symbol or ticker of Hypera S.A. is HYPE3.SA.
Which industry does the Hypera S.A. company belong to?
The Hypera S.A. industry is Drug Manufacturers-Specialty & Generic.
How many shares does Hypera S.A. have in circulation?
The max supply of Hypera S.A. shares is 633.06M.
What is Hypera S.A. Price to Earnings Ratio (PE Ratio)?
Hypera S.A. PE Ratio is 11.64728600 now.
What was Hypera S.A. earnings per share over the trailing 12 months (TTM)?
Hypera S.A. EPS is 2.58 BRL over the trailing 12 months.
Which sector does the Hypera S.A. company belong to?
The Hypera S.A. sector is Healthcare.
Hypera S.A. HYPE3.SA included in indexes
Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
---|
Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
---|---|---|---|---|---|---|---|
{{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
IVBX2 IVBX | 13742.55 BRL 2785.39 USD |
-1.49
|
— — | — — | — — | — - | — — |
IBRX 50 IBX50 | 21050.1 BRL 4266.51 USD |
-1.06
|
— — | — — | — — | — - | — — |
IGOVERNANCA IGCX | 19795.8 BRL 4012.28 USD |
-1.32
|
— — | — — | — — | — - | — — |
IBOVESPA BVSP | 125946.09 BRL 25527.2 USD |
-1.14
|
— — | — — | — — | — - | — — |
- {{ link.label }} {{link}}